Nu Skin Enterprises (NYSE:NUS) Issues Earnings Results, Beats Estimates By $0.04 EPS

Nu Skin Enterprises (NYSE:NUS) issued its quarterly earnings data on Thursday. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04, Briefing.com reports. The business had revenue of $439.10 million during the quarter, compared to analyst estimates of $431.87 million. Nu Skin Enterprises had a negative net margin of 0.17% and a positive return on equity of 9.28%. The firm’s quarterly revenue was down 12.2% on a year-over-year basis. During the same quarter last year, the business earned $0.54 EPS. Nu Skin Enterprises updated its FY24 guidance to $0.75-0.95 EPS and its Q3 guidance to $0.08-0.18 EPS.

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS opened at $10.02 on Monday. The company has a current ratio of 2.09, a quick ratio of 1.24 and a debt-to-equity ratio of 0.56. The stock’s fifty day simple moving average is $11.28 and its two-hundred day simple moving average is $12.90. Nu Skin Enterprises has a 1-year low of $9.74 and a 1-year high of $25.36. The stock has a market cap of $497.66 million, a PE ratio of -167.83 and a beta of 1.13.

Nu Skin Enterprises Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 11th. Shareholders of record on Friday, August 30th will be paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 2.40%. The ex-dividend date of this dividend is Friday, August 30th. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently -400.00%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. DA Davidson decreased their target price on shares of Nu Skin Enterprises from $15.50 to $12.50 and set a “neutral” rating for the company in a research report on Thursday, May 9th. Citigroup reduced their price objective on shares of Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating for the company in a research report on Friday. Four investment analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $17.00.

Insider Buying and Selling at Nu Skin Enterprises

In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of the firm’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $13.33, for a total transaction of $26,660.00. Following the transaction, the director now directly owns 23,225 shares in the company, valued at approximately $309,589.25. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.70% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.